Advanced Filters
noise

atrial-fibrillation Clinical Trials

A listing of atrial-fibrillation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 463 clinical trials
S Sanjiv Narayan, MD

The Dynamics of Human Atrial Fibrillation

Atrial fibrillation (AF) is an enormous public health problem in the United States, affecting 2-5 million Americans and causing rapid heart beats, stroke, heart failure or death. In this project, the applicant will develop a novel framework to better understand human AF that builds on agreement between several concepts for …

22 - 80 years of age All Phase N/A
M Mehrnoosh Hossein beky

Excessive Supraventricular Activity and Atrial Fibrillation

The aim of the proposed study is to determine if individuals with excessive supraventricular ectopic activity (ESVEA) on Holter recording should be subjected to prolonged screening with Event loop recorder in order to detect previously undiagnosed Atrial fibrillation / flutter. Other biomarkers such as plasma biomarkers, high-end echocardiography and assessment …

70 - 89 years of age All Phase N/A
T Thepakorn Sathitkarnmanee, MD

Postoperative Atrial Fibrillation in Cardiac Surgery

This multicenter observational study aims to investigate the incidence and identify risk factors associated with postoperative atrial fibrillation (POAF) in patients undergoing cardiac surgery at three medical centers in Thailand. The study will examine patient characteristics, surgical factors, and anesthetic management practices that may contribute to the development of this …

18 years of age All Phase N/A
A Adam Femerling Langhoff, MD

The COLchicine and Atrial FIBrillation Trial

The purpose of this study to investigate the effects of colchicine on atrial fibrillation recurrence and vascular and cardiac function in patients with atrial fibrillation.

18 years of age All Phase 3
B Bonaventure Yiu Ming IP, MB ChB

DOAC in Chinese Patients With Atrial Fibrillation

Direct oral anticoagulants (DOACs) have emerged as safe and efficacious ischemic stroke prophylaxis for non-valvular atrial fibrillation (NVAF). All four DOACs - apixaban, dabigatran, edoxaban, and rivaroxaban - were shown to reduce the risk of major bleeding compared to warfarin. The predictable pharmacokinetic profiles of DOACs also favour their use …

18 - 80 years of age All Phase N/A
P Piotr Sobocinski Doliwa, M.D. Ph.D.

Progression of Atrial Fibrillation in the Young

The purpose of this study is to investigate the presence and magnitude of structural changes of the heart and their long-term development in young patients with atrial Fibrillation (AF), studied by echocardiographic measurements and plasma biomarkers and their association to AF burden, studied using long-term ECG

18 - 50 years of age All Phase N/A
P Peter Watkinson, MD

Tracking Atrial Fibrillation After Intensive Care Admission

Atrial fibrillation (AF) is a heart problem that causes an irregular heartbeat. It can cause the heart to beat more rapidly and reduce the heart's ability to pump blood around the body efficiently, causing heart failure. It also increases the risk of blood clots forming inside the heart. These clots …

16 years of age All Phase N/A
J Jussi A Hernesniemi, MD, PhD

Acute Atrial Fibrillation and Flutter Treated Electively

The AFFELECT -study compares two types of treatment modalities for acute atrial fibrillation or flutter for patients in whom rhythm control is desirable. The main purpose is to observe if these arrhythmias can be safely treated electively (within 5-9 days). All patients are recruited in the emergency department. Patients must …

years of age All Phase N/A

DUTCH Weight Control in Atrial Fibrillation Study

Quantify the effect of an innovative weight loss management on rhythm control.

18 years of age All Phase 4
C Charlotte Fitzhugh

Exercise-based Cardiac Rehabilitation for Atrial Fibrillation

The investigators aim to conduct a pilot randomised controlled trial (RCT) with embedded feasibility study to evaluate an exercise-based cardiac rehabilitation (ExCR) programme when delivered to patients with atrial fibrillation on the waiting list for catheter ablation. Our overall objective is to test the feasibility and acceptability of an evidence-based …

18 years of age All Phase N/A

Simplify language using AI